Abiraterone Acetate Soft Capsules(Hangzhou Heze Pharma)

醋酸阿比特龙软胶囊（浙江和泽医药）

Report date: 2026/05/12 20:00:17

Base Information

Drug NameAbiraterone Acetate Soft Capsules(Hangzhou Heze Pharma)

Drug Alias NameAbiraterona乙酸阿比特龙酯Abiraterone acetate fine particle阿比特隆Abirateronum +[11]

ClassificationSmall molecules > SteroidsSmall molecules > Prodrug

Mechanisms of ActionSteroid 17-alpha-hydroxylase inhibitors

TargetsSteroid 17-alpha-hydroxylase

Therapy Area/IndicationsHormone-Sensitive Prostate NeoplasmsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHormone-Sensitive Prostate NeoplasmsProstatic Neoplasms, Castration-Resistant

Inactive IndicationsN/A

ATC CodeN/A